Table 2.
Addiction related Intake and outcome variables by insurance status and continued bup/nx use at follow-up.
| Variable (endorsed) Using bup/nx at follow-up | Total (N = 110) | Uninsured |
Insured |
Insureda |
bup/nx at follow-upb |
||||
|---|---|---|---|---|---|---|---|---|---|
| No (N = 12) | Yes (N = 50) | No (N = 13) | Yes (N = 35) | 44% (48/110) |
77% (85/110) |
||||
| χ 2 | P | χ 2 | P | ||||||
| Intake variables | |||||||||
| Minority | 27/110 (25%) | 1 (8%) | 9 (18%) | 6 (46%) | 11 (31%) | 6.82 | 0.009 | NS | |
| Female | 35/110 (32%) | 3 (25%) | 12 (24%) | 5 (38%) | 15 (43%) | NS | NS | ||
| Significant other | 45/68 (66%) | 2 (29%) | 7 (44%) | 11 (85%) | 25 (78%) | 12.4 | 0.0004 | NS | |
| Who is using | 9/67 (13%) | 0 (0%) | 1 (7%) | 2 (15%) | 6 (19%) | NS | NS | ||
| Prescription opioid use | 12/107 (11%) | 0 (0%) | 3 (6%) | 2 (15%) | 7 (20%) | NS | 3.13 | 0.0768c | |
| Route: injection | 78/110 (71%) | 10 (83%) | 41 (82%) | 9 (69%) | 18 (51%) | NS | NS | ||
| Medical comorbidity | 21/64 (33%) | 3 (50%) | 7 (54%) | 4 (31%) | 7 (22%) | NS | NS | ||
| Hepatitis C | 20/64 (31%) | 2 (33%) | 7 (54%) | 4 (31%) | 7 (22%) | NS | NS | ||
| Abscess | 5/63 (8%) | 1 (17%) | 2 (15%) | 0 (0%) | 2 (6%) | 2.77 | 0.0963c | NS | |
| Overdose | 3/66 (5%) | 0 (0%) | 1 (7%) | 0 (0%) | 2 (6%) | NS | NS | ||
| Depression | 43/110 (39%) | 7 (58%) | 16 (32%) | 6 (46%) | 14 (40%) | NS | NS | ||
| History of psychiatric treatment | 42/110 (38%) | 5 (42%) | 18 (36%) | 6 (46%) | 13 (37%) | NS | NS | ||
| Legal comorbidity | 69/106 (65%) | 9 (82%) | 32 (67%) | 7 (54%) | 21 (62%) | NS | NS | ||
| Arrest history | 17/63 (27%) | 4 (67%) | 4 (31%) | 3 (23%) | 6 (19%) | NS | NS | ||
| Any legal problems | 66/106 (62%) | 9 (82%) | 32 (67%) | 6 (46%) | 19 (56%) | 3.01 | 0.0827c | NS | |
| Outcome variables | |||||||||
| Substance use | 16/110 (15%) | 4 (33%) | 7 (14%) | 4 (31%) | 1 (3%) | 4.09 | 0.0432 | 6.26 | 0.0123 |
| Alcohol | 8/110 (7%) | 3 (25%) | 4 (8%) | 1 (8%) | 0 (0%) | 4.95 | 0.026 | 3.8 | 0.0513c |
| Heroin | 14/110 (13%) | 4 (33%) | 7 (14%) | 3 (23%) | 0 (0%) | 7.97 | 0.0047 | 8.1 | 0.0044 |
| Cocaine | 8/110 (7%) | 1 (8%) | 5 (10%) | 1 (8%) | 1 (3%) | NS | NS | ||
| AA affiliated | 95/110 (86%) | 9 (75%) | 46 (92%) | 7 (54%) | 33 (94%) | NS | 5.49 | 0.0191 | |
| Home group | 83/110 (76%) | 8 (67%) | 41 (84%) | 4 (31%) | 30 (86%) | NS | 3.40 | 0.0654c | |
| Has sponsor | 88/110 (80%) | 9 (75%) | 43 (86%) | 5 (38%) | 31 (89%) | NS | 4.72 | 0.0298 | |
| 3+ meetings/week | 73/110 (66%) | 6 (50%) | 38 (76%) | 6 (46%) | 23 (66%) | NS | NS | ||
| Employment characteristics | |||||||||
| Employed—baseline | 26/110 (24%) | 1 (8%) | 6 (12%) | 4 (31%) | 15 (43%) | 4.84 | 0.0278 | 4.92 | 0.0266 |
| Employed—follow-up | 64/110 (58%) | 2 (17%) | 32 (64%) | 7 (54%) | 23 (66%) | NS | 4.89 | 0.0271 | |
| Employment changes | n/a | n/a | n/a | n/a | n/a | NS | 2.84 | 0.0918c | |
| Still not employed | 43/110 (39%) | 10 (83%) | 18 (36%) | 5 (38%) | 10 (29%) | n/a | n/a | ||
| Still employed | 23/110 (21%) | 1 (8%) | 6 (12%) | 3 (23%) | 13 (37%) | n/a | n/a | ||
| Newly employed | 3/110 (3%) | 1 (8%) | 26 (52%) | 4 (31%) | 10 (29%) | n/a | n/a | ||
| No longer employed | 41/110 (37%) | 0 (0%) | 0 (0%) | 11 (8%) | 2 (6%) | n/a | n/a | ||
Analyses control for baseline medical and legal comorbidity. Uninsured = Self-pay classification; Insured = Insured, Medicaid, Medicare (Medicaid and Medicare are considered insured by St. Vincent Charity Hospital standards). NS = not significant (α = p < 0.05).
a
Test statistics for group difference across insured and uninsured groups.
b
Test statistics for group difference across those who did and those who did not report current bup/nx use at follow-up.
c
Trend level observation (p < 0.1).